| Central carbon metabolism in cancer |
2.04 |
0.00e+0 |
67/70 (95.71%) |
PKM;PFKP;GLS;...
|
| Colorectal cancer |
1.92 |
2.84e-2 |
84/86 (97.67%) |
AREG;CCND1;SMAD3;...
|
| Prostate cancer |
1.85 |
3.47e-2 |
93/97 (95.88%) |
CCND1;E2F3;PDGFRA;...
|
| Endometrial cancer |
1.84 |
3.31e-2 |
56/58 (96.55%) |
CCND1;CDH1;SOS2;...
|
| Melanoma |
1.81 |
3.22e-2 |
68/72 (94.44%) |
CCND1;E2F3;PDGFRA;...
|
| Retrograde endocannabinoid signaling |
-1.59 |
4.77e-2 |
118/148 (79.73%) |
GNAI3;GNB1;GNAI1;...
|
| Leishmaniasis |
-1.59 |
4.55e-2 |
67/77 (87.01%) |
IFNGR2;ITGAM;TGFB2;...
|
| Sphingolipid metabolism |
-1.59 |
4.73e-2 |
32/49 (65.31%) |
GLB1;PLPP1;SPTLC2;...
|
| Phagosome |
-1.60 |
4.62e-2 |
118/152 (77.63%) |
NCF4;ATP6V0E1;RAB5B;...
|
| Amyotrophic lateral sclerosis |
-1.61 |
4.59e-2 |
267/364 (73.35%) |
NDC1;COX6A1;RAB1A;...
|
| Thermogenesis |
-1.61 |
4.66e-2 |
173/232 (74.57%) |
COX7A1;COX6B1;CNR1;...
|
| Metabolism of xenobiotics by cytochrome P450 |
-1.62 |
4.24e-2 |
49/77 (63.64%) |
CYP1A2;CYP2B6;CYP2A6;...
|
| Vibrio cholerae infection |
-1.65 |
3.63e-2 |
44/50 (88%) |
ATP6V1C1;ATP6V1D;ATP6V0A4;...
|
| Phototransduction |
-1.68 |
3.07e-2 |
21/29 (72.41%) |
CNGB1;GRK1;CALML4;...
|
| Lysosome |
-1.70 |
2.68e-2 |
115/128 (89.84%) |
ATP6V0D1;AP3B1;GALNS;...
|
| Cell adhesion molecules |
-1.71 |
2.41e-2 |
118/148 (79.73%) |
NRXN1;PDCD1;PTPRM;...
|
| Proteasome |
-1.74 |
1.81e-2 |
44/46 (95.65%) |
PSMB1;PSME1;ADRM1;...
|
| Non-alcoholic fatty liver disease |
-1.76 |
1.46e-2 |
126/155 (81.29%) |
COX7A1;COX6B1;SOCS3;...
|
| Intestinal immune network for IgA production |
-1.76 |
1.41e-2 |
38/48 (79.17%) |
CCR10;HLA-DOB;HLA-DQA1;...
|
| Protein processing in endoplasmic reticulum |
-1.77 |
1.44e-2 |
127/171 (74.27%) |
RPN1;SEC24A;SEC61B;...
|
| Viral myocarditis |
-1.77 |
1.55e-2 |
53/60 (88.33%) |
HLA-DOB;CD55;HLA-DQA1;...
|
| Hematopoietic cell lineage |
-1.80 |
1.06e-2 |
90/99 (90.91%) |
HLA-DOB;KITLG;CD55;...
|
| Complement and coagulation cascades |
-1.89 |
2.89e-3 |
76/85 (89.41%) |
C8B;PROC;FGA;...
|
| Prion disease |
-1.91 |
3.18e-3 |
209/273 (76.56%) |
MAPK11;NDUFA6;PSMB1;...
|
| Parkinson disease |
-2.00 |
0.00e+0 |
176/249 (70.68%) |
PLCG1;NDUFA6;PSMB1;...
|
| Asthma |
-2.02 |
0.00e+0 |
25/31 (80.65%) |
HLA-DOB;FCER1G;HLA-DQA1;...
|
| Type I diabetes mellitus |
-2.08 |
0.00e+0 |
38/43 (88.37%) |
ICA1;GAD1;HLA-DOB;...
|
| Graft-versus-host disease |
-2.10 |
0.00e+0 |
32/42 (76.19%) |
HLA-DOB;HLA-DQA1;KLRD1;...
|
| Allograft rejection |
-2.13 |
0.00e+0 |
32/38 (84.21%) |
HLA-DOB;HLA-DQA1;HLA-DMB;...
|
| Rheumatoid arthritis |
-2.14 |
0.00e+0 |
78/93 (83.87%) |
CTSL;TGFB2;CXCL8;...
|
| Autoimmune thyroid disease |
-2.17 |
0.00e+0 |
46/53 (86.79%) |
HLA-DOB;HLA-DQA1;HLA-DMB;...
|
| Antigen processing and presentation |
-2.27 |
0.00e+0 |
60/78 (76.92%) |
HLA-DOB;PSME2;HLA-DQA1;...
|
| Oxidative phosphorylation |
-2.38 |
0.00e+0 |
93/133 (69.92%) |
ATP6V1C1;COX6A2;ATP6V1D;...
|
